Reducing large proteins to small molecules yields more affordable drugs

Dec 05, 2013 by Bronwyn Adams
Reducing large proteins to small molecules yields more affordable drugs
Dr Bob Reid

(Phys.org) —University of Queensland researchers have pioneered a drug development technique that could pave the way for a new class of low-cost medicines.

The researchers, led by Professor David Fairlie and Dr Robert Reid from UQ's Institute for Molecular Bioscience (IMB), designed a technique that reduces large proteins to small molecules suitable for use as drugs.

Professor Fairlie said the result was a smaller, more affordable version of a powerful human inflammatory , complement protein C3a, that helps defend against disease.

C3a costs thousands of dollars per milligram to manufacture commercially and degrades in minutes in blood, making it too expensive and unstable to be easily used in medicines.

The researchers have designed a small molecule that retains the same potent activities of C3a but is much cheaper and more stable for .

"Despite the importance of proteins to nearly every function in the body, their use in science, industry and medicine is significantly restricted by their high cost and instability," Professor Fairlie said.

"A holy grail in chemistry has been to find a way to reduce large proteins down to much smaller, simpler and cheaper molecules with the same activities.

"We have done exactly that, opening up exciting new avenues for chemists to downsize valuable human proteins and obtain affordable new diagnostics and drugs for the detection and treatment of human diseases," he said.

Dr Reid said the team had identified the key components of the protein that fought disease.

"We have developed a way of using chemical scaffolds to control the molecule's shape and reproduce protein functionhe said.

The research, published in leading scientific journal Nature Communications, was supported by the National Health and Medical Research Council and the Australian Research Council.

Explore further: Digestive brilliance of breast milk unravelled

add to favorites email to friend print save as pdf

Related Stories

New research shows obesity is an inflammatory disease

Dec 02, 2013

Scientists have moved a step closer to an "obesity drug" that may block the effects of diets high in sugar and fats. In a new research report published in the December 2013 issue of The FASEB Journal, scientists show that t ...

New family of proteins linked to major role in cancer

Dec 01, 2013

(Medical Xpress)—Scientists have described a new family of proteins that appear to play a key role in cancer and might be targets for future cancer drugs. A major new study in the journal Nature sets out the structure of the ...

Recommended for you

Scientists find clues to cancer drug failure

Mar 02, 2015

Cancer patients fear the possibility that one day their cells might start rendering many different chemotherapy regimens ineffective. This phenomenon, called multidrug resistance, leads to tumors that defy ...

Oat breakfast cereals may contain a common mold-related toxin

Feb 25, 2015

Oats are often touted for boosting heart health, but scientists warn that the grain and its products might need closer monitoring for potential mold contamination. They report in ACS' Journal of Agricultural and Food Chemistry that s ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.